Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000006

Chief Scientific Officer sold 40,000 shares at $31.47 ($1,258,800)

  • Chief Scientific Officer acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-27 Exercise or conversion : show line 1 in the form +40,000 $19.47 $778,800 305,922 D
2021-04-27 Sale : show line 2 in the form −40,000 $31.47 $1,258,800 265,922 D
Open-market sales · 40,000 sh · avg $31.47 · $1,258,800

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-27 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) −40,000 88,000 D
Loading xslF345X03/edgardoc.xml…